发明名称 |
Method of producing the polypeptide for treating virus-induced cancer |
摘要 |
The present invention relates to methods of producing the polypeptides that are capable of killing cells. The polypeptides comprise a targeting agent covalently attached to a channel-forming moiety. In a preferred embodiment, the channel-forming moiety comprises a colicin and the targeting agent is a reconstructed antibody mimetic derived from monoclonal antibody variants against Epstein-Barr virus gp350/220. |
申请公布号 |
US8802397(B2) |
申请公布日期 |
2014.08.12 |
申请号 |
US201213708760 |
申请日期 |
2012.12.07 |
申请人 |
Pheromonicin Biotech, Ltd. |
发明人 |
Qiu Xiao-Qing |
分类号 |
C12P21/00;A61K38/16;C07K14/705;C07K14/32;A61K47/48;C07K16/08;C07K14/24;C07K14/34;C12N15/62;C07K14/21;C07K14/245;A61K38/00 |
主分类号 |
C12P21/00 |
代理机构 |
Maschoff Brennan |
代理人 |
Maschoff Brennan |
主权项 |
1. A method of producing a fusion polypeptide for treating a cell proliferative disorder in a mammal, the fusion polypeptide comprising a cancer cell targeting agent that targets mammalian cancer cells covalently attached to a channel-forming moiety so as to have an anti-cell proliferative activity on mammalian cancer cells, wherein said channel forming moiety is a channel-forming peptide or channel-forming fragment thereof that is selected from the group consisting of an E1, Ia, Ib, A, K or N colicin, the method comprising:
culturing a host cell such that said fusion polypeptide is produced, wherein said host cell comprises a vector comprising a nucleic acid molecule encoding the fusion polypeptide. |
地址 |
Road Town VG |